Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
kidney disease
Biotech
Vertex pays $4.9 billion to hike Alpine’s immunology trail
Vertex's proposed acquisition of Alpine comes as immunology treatments attract significant investment.
Max Bayer
Apr 10, 2024 5:30pm
Equillium delivers new lupus data to Ono's doorstep
Apr 1, 2024 10:53am
AstraZeneca axes IL-33 kidney disease program after seeing data
Feb 8, 2024 5:30am
Procyrion raises $57M to complete its percutaneous heart pump
Feb 5, 2024 11:35am
ZyVersa taps George Clinical to run kidney disease trial
Dec 20, 2023 4:51pm
Novartis' $3.2B Chinook bet takes flight as phase 3 hits goal
Oct 30, 2023 8:16am